Evercore ISI Initiates Coverage on Danaher (DHR)

Analysts at Evercore ISI assumed coverage on shares of Danaher (NYSE:DHR) in a research note issued to investors on Wednesday, The Fly reports. The brokerage set an “outperform” rating on the conglomerate’s stock.

Several other brokerages also recently issued reports on DHR. Robert W. Baird reissued a “buy” rating and set a $99.00 price objective on shares of Danaher in a research report on Friday, December 15th. Citigroup raised their target price on shares of Danaher to $107.00 and gave the company a “buy” rating in a research report on Friday, December 15th. Zacks Investment Research raised shares of Danaher from a “hold” rating to a “buy” rating and set a $97.00 price objective for the company in a research report on Thursday, October 5th. Cowen reissued a “buy” rating and issued a $90.00 price objective on shares of Danaher in a research report on Wednesday, October 4th. Finally, Credit Suisse Group reissued a “hold” rating and issued a $99.00 price objective on shares of Danaher in a research report on Tuesday, December 19th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $94.38.

Shares of Danaher (NYSE DHR) traded up $1.23 during midday trading on Wednesday, reaching $93.67. 2,474,514 shares of the company traded hands, compared to its average volume of 3,049,150. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.43 and a quick ratio of 1.00. The firm has a market capitalization of $65,160.00, a price-to-earnings ratio of 27.88, a P/E/G ratio of 2.02 and a beta of 1.03. Danaher has a fifty-two week low of $78.65 and a fifty-two week high of $95.16.

Danaher (NYSE:DHR) last posted its earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.95 by $0.05. The company had revenue of $4.53 billion for the quarter, compared to analyst estimates of $4.47 billion. Danaher had a net margin of 13.36% and a return on equity of 11.29%. The business’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period last year, the business posted $0.87 earnings per share. equities research analysts anticipate that Danaher will post 3.99 earnings per share for the current fiscal year.

In related news, CAO Robert S. Lutz sold 11,189 shares of the stock in a transaction dated Monday, October 23rd. The shares were sold at an average price of $91.66, for a total transaction of $1,025,583.74. Following the completion of the transaction, the chief accounting officer now owns 18,314 shares in the company, valued at $1,678,661.24. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, SVP Daniel Raskas sold 37,870 shares of the stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $93.33, for a total transaction of $3,534,407.10. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 273,810 shares of company stock worth $25,218,813. Corporate insiders own 12.20% of the company’s stock.

A number of large investors have recently modified their holdings of the business. Neville Rodie & Shaw Inc. grew its position in Danaher by 1.3% during the fourth quarter. Neville Rodie & Shaw Inc. now owns 51,562 shares of the conglomerate’s stock valued at $4,786,000 after acquiring an additional 650 shares during the last quarter. Prudential Financial Inc. grew its holdings in shares of Danaher by 5.2% in the third quarter. Prudential Financial Inc. now owns 2,628,584 shares of the conglomerate’s stock worth $225,480,000 after purchasing an additional 130,621 shares during the last quarter. Atlantic Trust Group LLC grew its holdings in shares of Danaher by 7.9% in the third quarter. Atlantic Trust Group LLC now owns 2,223,836 shares of the conglomerate’s stock worth $190,762,000 after purchasing an additional 163,306 shares during the last quarter. Parametric Portfolio Associates LLC grew its holdings in shares of Danaher by 6.2% in the third quarter. Parametric Portfolio Associates LLC now owns 1,612,412 shares of the conglomerate’s stock worth $138,313,000 after purchasing an additional 94,344 shares during the last quarter. Finally, AXA grew its holdings in shares of Danaher by 1.9% in the third quarter. AXA now owns 906,949 shares of the conglomerate’s stock worth $77,798,000 after purchasing an additional 16,565 shares during the last quarter. Hedge funds and other institutional investors own 76.05% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Evercore ISI Initiates Coverage on Danaher (DHR)” was first published by American Banking News and is owned by of American Banking News. If you are reading this story on another website, it was illegally stolen and reposted in violation of US and international copyright legislation. The correct version of this story can be accessed at https://www.americanbankingnews.com/2018/01/03/evercore-isi-initiates-coverage-on-danaher-dhr.html.

Danaher Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

The Fly

Analyst Recommendations for Danaher (NYSE:DHR)

Leave a Reply